Meet in Italy for Life Sciences Brokerage Event 2026

13 – 14 Oct 2026 | Roma, Italy

TAKIS SRL

Company/Start-up

www.takisbiotech.it/rome, Italy
45 profile visits

About

Takis is a biotechnology company specializing in the research and development of innovative immunotherapies for infectious diseases and oncology. Its expertise includes DNA vaccines and humanized monoclonal antibodies. The company is equipped with BSL3 facilities for research on high-risk pathogens and GMP laboratories for the production of clinical-grade nucleic acids. Takis developed COVID-eVax, a DNA-based COVID-19 vaccine demonstrated to be safe and immunogenic in a first-in-human Phase 1 trial.

Takis provides fee-for-service solutions, including preclinical in vitro and in vivo studies, monoclonal antibody generation, vaccine development, and customized immune-oncology research services.

Social media

Areas of activity

Life Science Domain

PharmaResearch

Research

Clinical research (CRO)Preclinical & translational research

Pharma

OncologyVaccines & immunology

Representatives

Marketing Team Leader

TAKIS SRL

Chief Technology Officer

TAKIS SRL

Marketplace (4)

  • Service

    Custom antibodies

    Efficient antibody generation suitable for poorly immunogenic antigens.

    Author

    Marketing Team Leader at TAKIS SRL

    rome, Italy

  • Service

    Custom recombinant antibodies

    Recombinant antibodies ensure a safe long-term supply, with minimal batch-to-batch variation.

    Author

    Marketing Team Leader at TAKIS SRL

    rome, Italy

  • Service

    Next-generation vaccines development

    We can generate innovative genetic vaccines able to induce a strong immune response while minimizing potential undesired effects.

    Author

    Marketing Team Leader at TAKIS SRL

    rome, Italy